209 related articles for article (PubMed ID: 16949072)
1. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
Shiota N; Shimoura K; Okunishi H
Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
[TBL] [Abstract][Full Text] [Related]
2. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
4. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
[TBL] [Abstract][Full Text] [Related]
5. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
6. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
7. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
8. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
10. The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice.
Shiota N; Kovanen PT; Eklund KK; Shibata N; Shimoura K; Niibayashi T; Shimbori C; Okunishi H
Br J Pharmacol; 2010 Feb; 159(3):626-35. PubMed ID: 20067475
[TBL] [Abstract][Full Text] [Related]
11. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
[TBL] [Abstract][Full Text] [Related]
12. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
13. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.
Malfait AM; Malik AS; Marinova-Mutafchieva L; Butler DM; Maini RN; Feldmann M
J Immunol; 1999 May; 162(10):6278-83. PubMed ID: 10229875
[TBL] [Abstract][Full Text] [Related]
14. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
15. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
17. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast.
Kabasakal L; Sener G; Cetinel S; Contuk G; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):431-40. PubMed ID: 15890506
[TBL] [Abstract][Full Text] [Related]
18. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
20. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
